KU School of Medicine-Wichita Department of Pediatrics and Wesley Children’s Hospital say a groundbreaking treatment for ...

With its acceptance by the NMPA, NVK002 is now under regulatory review across three major global markets: the United States, ...

Medexus will target a commercial launch in 1H CY2025; potential for annual product-level revenue to exceed US$100 million ...

(Department of Justice via AP, File) WASHINGTON (AP) — The Justice Department is rescinding its protocol for federal executions that allowed for single-drug lethal injections ... s order to withdraw ...

A team of health policy experts has accused US state penitentiaries of stockpiling drugs that are urgently needed to treat the country’s almost 1 million COVID-19 patients. That’s because the drugs ...

Rising drug prices remain a contentious issue in the US. Credit: Malte Mueller via Getty Images. At the 2025 JP Morgan Healthcare Conference, GoodRx’s recently appointed CEO Wendy Barnes highlighted ...

Lexaria believes that an effective oral version of tirzepatide with fewer adverse events than the current injectable versions, could be highly valued. Oral delivery of drugs requires far higher ...

Read more about steroid therapy for MS flare-ups. While the drugs listed above help treat MS, a range of medications are available to treat the different physical symptoms that MS can cause.

Learn about the consultation and how to provide your feedback. The consultation closes on March 8, 2025. Drugs included on the list for exceptional importation and sale are called "designated drugs".

Lexaria has completed other research with oral DehydraTECH-processed semaglutide, sold by Novo Nordisk®, which is the only GLP-1 drug available today both in an oral form (Rybelsus®) and as an ...

As with Wegovy, adults with type 2 diabetes use the once-weekly injectable drug Ozempic to help control their blood sugar levels. Despite Ozempic not being classified as a weight-loss medication ...

After suspending executions in the spring of 2022, because of questions surrounding lethal injection drugs, Tenn. now says it is ready to resume scheduling executions for the 46 people on death row.